Filing status
- Accounts due
- 31 May 2027
- Last accounts
- 31 August 2025
- Conf. stmt due
- 29 December 2026
- Last conf. stmt
- 15 December 2025
LA Pharma Limited
- Incorporated
- 15 December 2003 (22 years)
- Industry
- Dispensing chemist in specialised stores (47730)
- Accounts type
- Total exemption full
- Region
- Greater London
- Address
- 83-85 Baker StreetLondonW1U 6AG
Charges
- Total
- 8
- Outstanding
- 6
- Part satisfied
- 0
- Satisfied
- 2
Officers 5 active
Officer details are public data from the Companies House register.
British
Born May 1977 (49)
Director · Appointed 11 March 2005
Also at Pharmsmart Limited, LA Pharma Property Limited (proposed for strike-off), Carter (2005) Property Limited · more companies
British
Born July 1976 (50)
Secretary · Appointed 13 January 2004
Also at Opd Laboratories Limited, Pharmsmart Limited, LA Pharma Property Limited (proposed for strike-off) · more companies
British
Director · Appointed 13 January 2004
Also at Opd Laboratories Limited, Pharmsmart Limited, LA Pharma Property Limited (proposed for strike-off) · more companies
British
Born October 1978 (48)
Director · Appointed 13 January 2004
British
Born November 1978
Officer history (2 former)
11 March 2005
11 March 2005
13 January 2004
13 January 2004
13 January 2004
15 December 2003
15 December 2003
15 December 2003
15 December 2003
Ownership 2 active
People and entities with significant control, from the Companies House PSC register
Private Limited Company
Reg. no. 04725469
Private Limited Company
Reg. no. 05371655
Group structure 18 companies
Ownership group derived from the Companies House PSC register
BMK Properties Limited Owns 75–100% of shares
Carter Chemist (2005) Limited Owns 50–75% of shares
LA Pharma Limited This company Owns 25–50% of shares
Valebret Limited Owns 75–100% of shares
Carter Chemist Limited Owns 75–100% of shares
H D Dental Limited Owns 75–100% of shares
Health Dispense Limited Owns 25–50% of shares
Health Dispense Property Company Limited Owns 75–100% of shares
Sigcare Limited Owns 75–100% of shares
Sigma Pharmaceuticals PLC Owns 75–100% of shares
Opd Laboratories Limited Owns 75–100% of shares
RX Farma Limited Owns 75–100% of shares
Selective Supplies Limited Owns 75–100% of shares
Special Concept Development (UK) Limited Owns 75–100% of shares
Sigma Properties Limited Owns 75–100% of shares
Tsu (Europe) Limited Owns 25–50% of shares
Financials
Balance sheet as at 31 August 2025 · total exemption full accounts
- Net Assets
- (£433,868)
- Cash
- £116,468
- Profit
- (£35,478)
- Debt Ratio
- 116%
- Current Ratio
- 0.9x
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Fixed Assets | £1,396,888 | £1,446,102 | £1,500,453 | £1,610,235 | £1,992,011 |
| Current Assets | £1,238,378 | £1,247,721 | £1,236,764 | £973,711 | £738,900 |
| Debtors | £912,720 | £895,574 | £886,122 | £782,531 | £562,827 |
| Cash | £116,468 | £138,687 | £110,943 | £15,372 | £82,779 |
| Creditors (< 1 year) | £1,332,680 | £1,217,312 | £1,102,741 | £2,856,277 | £1,333,289 |
| Creditors (> 1 year) | £1,736,454 | £1,874,901 | £1,977,653 | £0 | £1,670,498 |
| Net Current Assets | (£94,302) | £30,409 | £134,023 | (£1,882,566) | (£594,389) |
| Net Assets | (£433,868) | (£398,390) | (£343,177) | (£272,331) | (£272,876) |
| Shareholder Funds | (£433,868) | (£398,390) | (£343,177) | (£272,331) | (£272,876) |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 22 May 2026 | Total exemption full accounts | 31 August 2025 | ||
| 7 April 2026 | Change of details for a person with significant control | |||
| 30 March 2026 | Director's details changed | |||
| 30 March 2026 | Director's details changed | |||
| 30 March 2026 | Secretary's details changed |
Some other companies at this address
Other companies in this industry
Cheltenham
Chester
Manchester
London
Leeds
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →